<HTML>
<HEAD>
<TITLE>Current Report for HAALO</TITLE>
</HEAD>
<BODY>

<p>&nbsp;</p>
<B><FONT SIZE=4><P ALIGN="CENTER">UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C.,  20549<BR>
</FONT><FONT SIZE=2><BR>

<BR>
</FONT><FONT SIZE=4>FORM 8-K<BR></FONT><BR>

<FONT SIZE=4>CURRENT REPORT</P>
</FONT><P ALIGN="CENTER">Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934</P>

<p align=center>Date of Report (Date of earliest event reported):  August 3, 2006</P>

<p align=center><FONT SIZE=5>Health Anti-Aging Lifestyle Options, Inc.</FONT> <BR>
 (Exact Name of Registrant as Specified in Its Charter)</P></B>

<br>

<p align=center><TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH=670>
<TR><TD WIDTH="33%" VALIGN="TOP">
<B><P ALIGN="CENTER">Utah<hr></B></TD>
<TD WIDTH="3%" VALIGN="TOP"></TD>
<TD WIDTH="34%" VALIGN="TOP">
<B><P ALIGN="CENTER">000-50068<hr></B></TD>
<TD WIDTH="4%" VALIGN="TOP"></TD>
<TD WIDTH="27%" VALIGN="TOP">
<B><P ALIGN="CENTER">90-0097142<hr></B></TD>
</TR>
<TR><TD WIDTH="33%" VALIGN="TOP">
<P ALIGN="CENTER">(State or other jurisdiction of incorporation)</TD>
<TD WIDTH="3%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="34%" VALIGN="TOP">
<P ALIGN="CENTER">(Commission File Number)</TD>
<TD WIDTH="4%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="27%" VALIGN="TOP">
<P ALIGN="CENTER">(IRS Employer Identification No.)</FONT></TD>
</TR>
<TR><TD WIDTH="33%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="34%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="27%" VALIGN="TOP">&nbsp;</TD>
</TR>
</TABLE>

<br>
<p align=center><TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH=680>
<TR><TD VALIGN="TOP">
<P ALIGN="CENTER">580 Hornby Street, Suite 210, Vancouver, British</TD>
</TR>
<TR><TD VALIGN="TOP">
<P ALIGN="CENTER">Columbia, Canada   V6C 3B6<hr></TD>
</TR>
<TR><TD VALIGN="TOP">
<P ALIGN="CENTER">(Address of principal executive offices)</TD>
</TR>
<TR><TD VALIGN="TOP">&nbsp;</TD>
</TR>
<TR><TD VALIGN="TOP">
<P ALIGN="CENTER">Registrant's telephone number, including area code: (604) 687-6991</TD>
</TR>
</TABLE>

<B><P ALIGN="CENTER">&nbsp;</P></B>

<P> Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </P>


<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=0 WIDTH=680>
<TR><TD WIDTH="3%" VALIGN="MIDDLE">&nbsp;</TD>
<TD WIDTH="97%" VALIGN="MIDDLE">&nbsp;</TD>
</TR>
<TR><TD WIDTH="3%" VALIGN="TOP">
<FONT FACE="Wingdings" SIZE=2><P>o</FONT><FONT FACE="New York,Times New Roman" SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="97%" VALIGN="TOP">
<FONT FACE="New York,Times New Roman" SIZE=2><P>Written communications pursuant to Rule&nbsp;425 under the Securities Act</FONT></TD>
</TR>
</TABLE>

<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=0 WIDTH=670>
<TR><TD WIDTH="3%" VALIGN="TOP">
<FONT FACE="Wingdings" SIZE=2><P>o</FONT><FONT FACE="New York,Times New Roman" SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="97%" VALIGN="TOP">
<FONT FACE="New York,Times New Roman" SIZE=2><P>Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act</FONT></TD>
</TR>
</TABLE>


<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=0 WIDTH=680>
<TR><TD WIDTH="3%" VALIGN="TOP">
<FONT FACE="Wingdings" SIZE=2><P>o</FONT><FONT FACE="New York,Times New Roman" SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="97%" VALIGN="TOP">
<FONT FACE="New York,Times New Roman" SIZE=2><P>Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act</FONT></TD>
</TR>
</TABLE>


<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=0 WIDTH=680>
<TR><TD WIDTH="3%" VALIGN="TOP">
<FONT FACE="Wingdings" SIZE=2><P>o</FONT><FONT FACE="New York,Times New Roman" SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="97%" VALIGN="TOP">
<FONT FACE="New York,Times New Roman" SIZE=2><P>Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act</FONT></TD>
</TR>
</TABLE>


<P>&nbsp;</P>
<P>&nbsp;</P>
<page>
<hr>

<br>
<B><U><P ALIGN="CENTER">TABLE OF CONTENTS</P></U></B>


<P>ITEM 5.02 &nbsp; &nbsp; Departure of Directors or Principal Officers: Election of Directors; Appointment of Principal officers</P>

<P>SIGNATURES</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<p align=center> - 2 - </p>
<page>
<hr>

<br>
<B><P>ITEM 5.02  - Departure of Directors or Principal Officers; Election of Directors; Appointment    of    Principal Officers</P></B>

<P>(a) &nbsp; &nbsp; On August 3, 2006, John Caton resigned as the Chief Financial Officer, Secretary-Treasurer and Director of Health Anti-Aging Lifestyle Options, Inc. (the &quot;Company&quot;).  Mr. Caton has resigned from his positions to pursue other personal interests.  At the time of his resignation, Mr. Caton possessed no Company securities, nor is he owed any compensation for his services rendered to the Company.</P>

<P>(b) &nbsp; &nbsp; On August 3, 2006, Bruce Schmidt was appointed Director, Chief Financial Officer, Secretary-Treasurer and Principal Accounting Officer of the Company.  Since May of 1996, Mr. Schmidt has been working as a Life-Sciences Management consultant under his own consulting company, RJS Management in Vancouver, BC.  RJS Management provides executive counsel to hightech/biotech companies in the areas of business strategy, marketing and strategic partnering.  </P>

<P>With a background in physics and education from the University of British Columbia, he has acted as a consultant and has served on the Board of Directors for a variety of Canadian biotech/hightech and venture capital companies between 1992 through 2005 including:  Prescient Neuropharma Inc.  (TSX- &quot;PNO&quot;) as President, Chief Executive Officer and Director;  Alda Pharmaceuticals Corp. (TSX-&quot;APH&quot;) as Director; Biophage Pharma Inc. (TSX-&quot;BUG&quot;) as Corporate Secretary and Director; Strategic Merchant Bancorp, Ltd (TSX-&quot;SMB&quot;) as a Director; VP Media Group Ltd. (TSX- &quot;DVD.H&quot;) as Director and Aitchison Capital, Inc. (TSX-&quot;TTI&quot;) as a Director.</P>

<P>Mr. Schmidt has also been involved with a number of non-profit Canadian organizations including: the Canadian Networks of Centers of Excellence, the Canadian Healthcare Licensing Association, the British Columbia Biotechnology Alliance (BC Biotech), B.C. Nanotechnology Alliance, British Columbia's Integrated Technology Initiative and the New Economy and Adoption of Technologies Group of the British Columbia Securities Commission. </P>

<P>Bruce Schmidt will receive no compensation for his services as Director, Chief Financial Officer, Secretary-Treasurer and Principal Accounting Officer of Health Anti-Aging Lifestyle Options, Inc.</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<p align=center> - 3 - </p>
<page>
<hr>
</FONT>

<B><P>&nbsp;</P>
<P ALIGN="CENTER">SIGNATURES</B><BR>
</P>
<P><BR>
<BR>
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </P><DIR>
<DIR>
<DIR>
<DIR>
<DIR>
<DIR>
<DIR>
<DIR>
<DIR>
<DIR>

<P><BR>
<B><BR>
HEALTH ANTI-AGING LIFESTYLE OPTIONS, INC.</B><FONT SIZE=2><BR>
</FONT><BR>
</P></DIR>
</DIR>

<P ALIGN="CENTER"><TABLE CELLSPACING=0 BORDER=0 CELLPADDING=0 WIDTH=500>
<TR><TD WIDTH="9%" VALIGN="TOP">
<P>By: </TD>
<TD WIDTH="91%" VALIGN="TOP">
<B><U><P>PETER HOGENDOORN</B></U></TD>
</TR>
<TR><TD WIDTH="9%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="91%" VALIGN="TOP">
<FONT FACE="New York,Times New Roman"><P>Peter Hogendoorn<BR>
President, Chief Executive Officer and Director</FONT></TD>
</TR>
</TABLE>
</P>
</DIR>
</DIR>
</DIR>
</DIR>
</DIR>
</DIR>
</DIR>
</DIR>


<P>&nbsp;</P>
<P>Dated:  August 8, 2006</P>


<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<p align=center> - 4 - </p>
<page>
<hr>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "haalo8k08082006.htm", "description": "CURRENT REPORT FOR HEALTH ANTI-AGING LIFESTYLE OPTIONS, INC.", "secsgml_size_bytes": 8201}]
{"company-data": {"conformed-name": "HEALTH ANTI AGING LIFESTYLE OPTIONS INC", "cik": "0000805902", "assigned-sic": "2840", "irs-number": "900097142", "state-of-incorporation": "UT", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-50068", "film-number": "061013993"}, "business-address": {"street1": "SUITE 210", "street2": "580 HORNBY STREET", "city": "VANCOUVER", "state": "A1", "zip": "V6C 3B6", "phone": "604-687-6991"}, "mail-address": {"street1": "SUITE 210", "street2": "580 HORNBY STREET", "city": "VANCOUVER", "state": "A1", "zip": "V6C 3B6"}, "former-company": [{"former-conformed-name": "MICROACCEL INC", "date-changed": "20000218"}, {"former-conformed-name": "HORTITECH INC", "date-changed": "19950927"}, {"former-conformed-name": "WESTERN ANTENNA CORP", "date-changed": "19920703"}]}
Current Report for HAALO
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.,  20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):  August 3, 2006
Health Anti-Aging Lifestyle Options, Inc.
(Exact Name of Registrant as Specified in Its Charter)
Utah
000-50068
90-0097142
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
580 Hornby Street, Suite 210, Vancouver, British
Columbia, Canada   V6C 3B6
(Address of principal executive offices)
Registrant's telephone number, including area code: (604) 687-6991
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
TABLE OF CONTENTS
ITEM 5.02     Departure of Directors or Principal Officers: Election of Directors; Appointment of Principal officers
SIGNATURES
- 2 -
ITEM 5.02  - Departure of Directors or Principal Officers; Election of Directors; Appointment    of    Principal Officers
(a)     On August 3, 2006, John Caton resigned as the Chief Financial Officer, Secretary-Treasurer and Director of Health Anti-Aging Lifestyle Options, Inc. (the "Company").  Mr. Caton has resigned from his positions to pursue other personal interests.  At the time of his resignation, Mr. Caton possessed no Company securities, nor is he owed any compensation for his services rendered to the Company.
(b)     On August 3, 2006, Bruce Schmidt was appointed Director, Chief Financial Officer, Secretary-Treasurer and Principal Accounting Officer of the Company.  Since May of 1996, Mr. Schmidt has been working as a Life-Sciences Management consultant under his own consulting company, RJS Management in Vancouver, BC.  RJS Management provides executive counsel to hightech/biotech companies in the areas of business strategy, marketing and strategic partnering.
With a background in physics and education from the University of British Columbia, he has acted as a consultant and has served on the Board of Directors for a variety of Canadian biotech/hightech and venture capital companies between 1992 through 2005 including:  Prescient Neuropharma Inc.  (TSX- "PNO") as President, Chief Executive Officer and Director;  Alda Pharmaceuticals Corp. (TSX-"APH") as Director; Biophage Pharma Inc. (TSX-"BUG") as Corporate Secretary and Director; Strategic Merchant Bancorp, Ltd (TSX-"SMB") as a Director; VP Media Group Ltd. (TSX- "DVD.H") as Director and Aitchison Capital, Inc. (TSX-"TTI") as a Director.
Mr. Schmidt has also been involved with a number of non-profit Canadian organizations including: the Canadian Networks of Centers of Excellence, the Canadian Healthcare Licensing Association, the British Columbia Biotechnology Alliance (BC Biotech), B.C. Nanotechnology Alliance, British Columbia's Integrated Technology Initiative and the New Economy and Adoption of Technologies Group of the British Columbia Securities Commission.
Bruce Schmidt will receive no compensation for his services as Director, Chief Financial Officer, Secretary-Treasurer and Principal Accounting Officer of Health Anti-Aging Lifestyle Options, Inc.
- 3 -
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
HEALTH ANTI-AGING LIFESTYLE OPTIONS, INC.
By:
PETER HOGENDOORN
Peter Hogendoorn
President, Chief Executive Officer and Director
Dated:  August 8, 2006
- 4 -